Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mirror-image polydactyly gene 1 protein (MIPOL1) is a coiled-coil domain-containing protein encoded by the MIPOL1 gene in humans, found on chromosome 14q13.3-q21.1[1][7]. Pathogenic variants are associated with mirror-image polydactyly (Laurin-Sandrow syndrome), characterized by duplication of digits. MIPOL1 plays important roles in developmental processes, particularly limb patterning and central nervous system development[1]. It acts as a tumor suppressor in nasopharyngeal carcinoma (NPC), where its downregulation correlates with disease, and restoration of its expression inhibits angiogenesis, invasion, and metastasis by regulating downstream targets such as p21 and p27 and interacting with other tumor suppressors like RhoB[1][3]. Evidence suggests MIPOL1 might also function as a transcriptional repressor[6]. While not currently established as a druggable target (such as a receptor or enzyme), its relevance in developmental disorders and certain cancers highlights its biomedical significance[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mirror-image polydactyly gene 1 protein (MIPOL1).